Resources from the same session
626MO - Tarlatamab in previously treated small cell lung cancer (SCLC): Subgroup analysis of patients from the Asia region in the phase II DeLLphi-301 study
Presenter: Hiroaki Akamatsu
Session: Mini Oral session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast
627MO - POD1UM-304: Phase III study of retifanlimab plus platinum-based chemotherapy (Chemo) as first-line (1L) therapy for nonsquamous or squamous metastatic non–small cell lung cancer (mNSCLC)
Presenter: Shun Lu
Session: Mini Oral session: Thoracic malignancies
Resources:
Abstract
Invited Discussant 626MO and 627MO
Presenter: Yang Xia
Session: Mini Oral session: Thoracic malignancies
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Thoracic malignancies
Resources:
Webcast
614MO - A phase II study of Becotatug (JMT101) in combination with osimertinib (Osi) in patients (pts) with classical EGFR-mutated non-small cell lung cancer (NSCLC) (BOOSTER Study)
Presenter: Li Zhang
Session: Mini Oral session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast
630MO - First-line (1L) osimertinib (osi) ± platinum-pemetrexed chemotherapy (CTx) for EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC): FLAURA2 Asian cohort
Presenter: James Chih-Hsin Yang
Session: Mini Oral session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Thoracic malignancies
Resources:
Webcast
628MO - Comparing subcutaneous vs intravenous amivantamab with lazertinib in EGFR-mutated advanced NSCLC: Analysis of Asian patients from PALOMA-3
Presenter: Se-Hoon Lee
Session: Mini Oral session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast
629MO - ALESIA 7-year update: Alectinib vs crizotinib in Asian patients (pts) with treatment-naïve advanced ALK+ non-small cell lung cancer (NSCLC)
Presenter: Thanyanan Baisamut
Session: Mini Oral session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant 628MO and 629MO
Presenter: Xiuning Le
Session: Mini Oral session: Thoracic malignancies
Resources:
Slides
Webcast